The nation’s top health officials say they’re rushing to make sure Americans can get widespread access to the experimental drug remdesivir after a study showed that it shortens the recovery time for some coronavirus patients.
The push to give the drug the regulatory approval it needs for broader distribution comes a day after the government’s top infectious disease expert, Anthony Fauci, called the drug “an important proof of concept” and compared it to the discovery of the earliest HIV treatments in the 1980s. Investors sent U.S. stocks surging after the news was announced.
Image: Rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the U.S. | Gilead Sciences via AP
